During the past decade, Chu Limoges - Cic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Limoges - Cic" #1 collaborator was "Innovative Medicines Initiative" with 2 trials as a collaborator and "Janssen Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chu Limoges - Cic" are "E. Coli Infection" (1 trials) and "E.Coli Infections" (1 trials). Many other conditions were trialed in "Chu Limoges - Cic" in a lesser frequency.

The vast majority of trials in "Chu Limoges - Cic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chu Limoges - Cic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chu Limoges - Cic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chu Limoges - Cic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".